|
|
Article: Dyax Cuts Staff, Discovery To Advance Lead Products.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
West Coast Editor
Add to the list of companies cutting back to save cash Dyax Corp., which said it will cut 21 of its 133 employees on the biopharmaceutical side of the business, thereby conserving $4 million to $5 million annually, and keep enough capital for two more years of operation.
"It's the objective to always have two years of cash in the bank," said Sondra Henrichon, director of investor relations for Cambridge, Mass.-based Dyax.
"We say two years, but what we mean by that number is that we believe we can take the company through 2004," she added.
Dyax uses phage display technology to identify proteins, peptides and ...
Related newspaper, magazine, and journal articles:
|
|
Article: Dyax To Receive $35M Through Biotage Sale To ...
BIOWORLD Today;
October 15, 2003 ;
700+ words
... ... sale of Biotage, Dyax, of Cambridge ... Stephen Galliker, Dyax's chief financial officer, told BioWorld Today. "We have several ... disease target. (See BioWorld Today, May 15, 2002 ... its own pipeline, Dyax and its partners ...
|
|